Index of reports
> Cases with Deep Vein Thrombosis (44)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neupogen (Filgrastim) where reactions include deep vein thrombosis. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 44 Next >>
Possible Neupogen side effects in 45 year old female
Reported by a physician from India on 2012-07-20
Patient: 45 year old female
Reactions: Thrombocytosis, Deep Vein Thrombosis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Neupogen
Other drugs received by patient: Aripiprazole
Possible Neupogen side effects in
Reported by a physician from United Kingdom on 2012-05-02
Patient:
Reactions: Abdominal Pain, Pneumonia Aspiration, Oral Candidiasis, Dizziness, Constipation, Deep Vein Thrombosis
Drug(s) suspected as cause:
Neupogen
Possible Neupogen side effects in
Reported by a physician from United Kingdom on 2012-05-02
Patient:
Reactions: Oral Candidiasis, Liver Function Test Abnormal, Pulmonary Embolism, Deep Vein Thrombosis
Drug(s) suspected as cause:
Neupogen
Possible Neupogen side effects in 68 year old male
Reported by a physician from Denmark on 2012-04-06
Patient: 68 year old male, weighing 81.0 kg (178.2 pounds)
Reactions: Klebsiella Infection, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-22
Prednisone TAB
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-22
Rituximab
Dosage: 800 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-22
Doxorubicin HCL
Dosage: 100 unk, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-22
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-23
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-22
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-03
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-30
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Agranulocytosis, Sepsis, Neutropenia, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 110 mg milligram(s),intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg milligram(s)intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s)intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg milligram(s) ( 1 day ) oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Clozapine
Dosage: 200 mg milligram(s) ( 1 day ) oral
Indication: Schizophrenia
Start date: 2011-12-02
Other drugs received by patient: Citalopram Hydrobromide
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-27
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-20
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutrophil Count Increased, Neutropenia, Deep Vein Thrombosis, White Blood Cell Count Increased, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg mgilligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mgilligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg mgilligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Citalopram Hydrobromide; (Amisulpride); (Pirenzepine)
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-15
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-12
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-02
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: 2 mg milligram(s), unknown, intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral, 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral, 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-02
Doxorubicin HCL
Dosage: 110 mg milligram(s), unknown, intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s), unknown, intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Cyclophosphamide
Dosage: 1600 milligram(s), unknown, intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s), unknown, unknown
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-29
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-01-12
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Clozapine
Start date: 2011-12-02
Neupogen
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-23
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Vincristine
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-09-22
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram Hydrobromide
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-23
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-23
Patient: 65 year old male, weighing 74.0 kg (162.8 pounds)
Reactions: Lung Infection, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 06 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-25
Vinblastine Sulfate
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-12-14
Doxorubicin HCL
Dosage: 98.5 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Rituximab
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Cyclophosphamide
Dosage: 1463 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Doxorubicin HCL
Start date: 2010-12-16
Vincristine Sulfate
Start date: 2010-12-16
Other drugs received by patient: Morphine; Oxycodone HCL; Metoprolol; Pantoprazole
Possible Neupogen side effects in 65 year old male
Reported by a physician from Denmark on 2012-02-22
Patient: 65 year old male, weighing 74.0 kg (162.8 pounds)
Reactions: Lung Infection, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 11.8 mg, unk
Start date: 2010-12-16
Rituximab
Dosage: 700 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Vinblastine Sulfate
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-12-14
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-25
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Doxorubicin HCL
Dosage: 97.5 mg, unk
Start date: 2010-12-16
Cyclophosphamide
Dosage: 1463 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
End date: 2010-12-01
Doxorubicin HCL
Dosage: 98.5 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Other drugs received by patient: Oxycodone; Morphine; Pantoprazole; Metoprolol
Possible Neupogen side effects in 42 year old male
Reported by a pharmacist from United Kingdom on 2012-02-21
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 110 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Neupogen
Dosage: 800 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Prednisolone
Dosage: 60 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Vincristine
Dosage: 2 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram Hydrobromide
Possible Neupogen side effects in 68 year old male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-02-10
Patient: 68 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1350 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Doxorubicin HCL
Dosage: 90 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Other drugs received by patient: Allopurinol; Acyclovir; Ondansetron; Bactrim
Possible Neupogen side effects in male
Reported by a physician from Denmark on 2012-02-08
Patient: male, weighing 70.0 kg (154.0 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1350 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Doxorubicin HCL
Dosage: 90 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Other drugs received by patient: Allopurinol; Ondansetron; Bactrim; Acyclovir
Possible Neupogen side effects in 55 year old male
Reported by a physician from Netherlands on 2012-02-07
Patient: 55 year old male
Reactions: Deep Vein Thrombosis, Erysipelas
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-15
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-15
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-16
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-15
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-15
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-15
Possible Neupogen side effects in 68 year old male
Reported by a physician from Denmark on 2012-02-02
Patient: 68 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-09-01
Cyclophosphamide
Dosage: 1350 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Rituximab
Dosage: 650 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Doxorubicin HCL
Dosage: 90 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-08-31
Other drugs received by patient: Acyclovir; Bactrim; Allopurinol; Ondansetron
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-30
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Agranulocytosis, Neutropenia, Diffuse Large B-Cell Lymphoma, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg milligram(s) intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-02
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Doxorubicin HCL
Dosage: 110 mg milligram(s), intravenous (not otherwise specified)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: (Pirenzeprine); (Citalopram); (Amisulpride)
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-26
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Neupogen
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-23
Clozapine
Start date: 2011-12-02
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Vincristine
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-09-22
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-01-12
Other drugs received by patient: Amisulpride; Citalopram Hydrobromide; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a pharmacist from United Kingdom on 2012-01-23
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: White Blood Cell Count Decreased, Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Cyclophosphamide
Dosage: 1600 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine
Dosage: 2 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Sepsis, Bone Marrow Failure, non-Hodgkin's Lymphoma, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Doxorubicin HCL
Dosage: 2 mg milligram(s), unknown intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Pirenzepine; Citalopram Hydrobromide; Amisulpride
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-20
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Other drugs received by patient: Citalopram; Amisulpride; Pirenzepine
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-17
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Leukopenia, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Cyclophosphamide
Dosage: 1600 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine Sulfate
Dosage: 2 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, 2x/day
Administration route: Oral
Start date: 2011-12-02
Neupogen
Dosage: 800 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Prednisolone
Dosage: 60 mg, daily
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Other drugs received by patient: Amisulpride; Pirenzepine; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-16
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, White Blood Cell Count Decreased, Agranulocytosis, Neutropenia, Neutrophil Count Decreased, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neupogen
Dosage: 800 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Cyclophosphamide
Dosage: 1600 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Vincristine
Dosage: 2 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Doxorubicin HCL
Dosage: 110 mg, one time dose
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Start date: 2011-12-02
Clozapine
Dosage: 200 mg, bid
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Other drugs received by patient: Amisulpride; Citalopram; Pirenzepine
Possible Neupogen side effects in male
Reported by a physician from Denmark on 2012-01-09
Patient: male, weighing 74.0 kg (162.8 pounds)
Reactions: Lung Infection, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Vincristine
Start date: 2010-12-16
Prednisone TAB
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-02-15
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Neupogen
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-25
Doxorubicin HCL
Start date: 2010-09-24
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-09-24
Doxorubicin HCL
Start date: 2010-12-16
Vinblastine Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2010-12-14
Other drugs received by patient: Morphine; Oxycodone HCL; Metoprolol Succinate; Pantoprazole
Possible Neupogen side effects in 42 year old male
Reported by a pharmacist from United Kingdom on 2012-01-04
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Deep Vein Thrombosis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Prednisolone
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Neupogen
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-23
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-11-22
Clozapine
Start date: 2011-12-02
Vincristine
Indication: Diffuse Large B-Cell Lymphoma Stage II
Start date: 2011-09-22
Clozapine
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-01-12
Other drugs received by patient: Pirenzepine; Amisulpride; Citalopram
Possible Neupogen side effects in 42 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-12-30
Patient: 42 year old male, weighing 104.0 kg (228.8 pounds)
Reactions: Diffuse Large B-Cell Lymphoma Stage II, Agranulocytosis, Neutropenia, Deep Vein Thrombosis, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral; 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2011-12-09
Clozapine
Dosage: 200 mg milligram(s), 1 day, oral; 200 mg milligram(s), 1 day, oral
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-09-15
End date: 2011-12-01
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Cyclophosphamide
Dosage: 1600 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Prednisolone
Dosage: 60 mg milligram(s)
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-22
Neupogen
Dosage: 800 mg milligram(s), intravenous
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-11-23
Other drugs received by patient: Pirenzepine; Citalopram Hydrobromide; Amisulpride
Page 1 Next >>
|